menu
    • menu

    Company profile for Priovant Therapeutics

    NEW Drugs in Dev: 1
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Priovant Therapeutics is a biotechnology company dedicated to developing innovative therapies for autoimmune and inflammatory diseases. Leveraging cutting-edge science and advanced therapeutic approaches, we focus on creating targeted treatments that address significant unmet medical needs in these challenging disease areas. Our mission is to improve the lives of patients by delivering safe, effective, and transformative thera...
    Priovant Therapeutics is a biotechnology company dedicated to developing innovative therapies for autoimmune and inflammatory diseases. Leveraging cutting-edge science and advanced therapeutic approaches, we focus on creating targeted treatments that address significant unmet medical needs in these challenging disease areas. Our mission is to improve the lives of patients by delivering safe, effective, and transformative therapies that offer hope and better health outcomes. At Priovant Therapeutics, we are committed to advancing healthcare through innovation, research, and patient-centered solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Priovant TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1007 Slater Road Suite 250 Durham, NC 27703
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.priovanttx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Priovant's Brepocitinib Nda For Dermatomyositis Accepted By FDA
    Priovant's Brepocitinib Nda For Dermatomyositis Accepted By FDA

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248199/34323/en/Priovant-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Brepocitinib-in-Dermatomyositis.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Priovant Reports Positive Phase 2 Data For Brepocitinib
    Priovant Reports Positive Phase 2 Data For Brepocitinib

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233726/34323/en/Priovant-Announces-Positive-Phase-2-Results-for-Brepocitinib-in-Cutaneous-Sarcoidosis-CS.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Roivant and Priovant's drug show Promising Result in Rare Disease
    Roivant and Priovant's drug show Promising Result in Rare Disease

    17 Sep 2025

    // PRESS RELEASE

    https://investor.roivant.com/news-releases/news-release-details/roivant-and-priovant-announce-positive-phase-3-valor-study

    PRESS RELEASE
    17 Sep 2025
    Share Share
    Roivant and Priovant to Host Investor Video Conference
    Roivant and Priovant to Host Investor Video Conference

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3096179/34323/en/Roivant-and-Priovant-to-Host-Investor-Video-Conference-at-1-00-PM-ET-on-Tuesday-June-17-on-Brepocitinib-and-the-Unmet-Medical-Need-in-Dermatomyositis.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search